
Take Solutions Ltd — Investor Relations & Filings
Take Solutions Ltd provides specialized domain-led technology and services, primarily focusing on the Life Sciences sector. Through its key brand, Navitas Life Sciences, the company delivers end-to-end solutions across clinical research, regulatory affairs, and pharmacovigilance. Its service offerings include clinical data management, medical writing, and trial monitoring, leveraging proprietary platforms to enhance operational efficiency. The organization supports pharmaceutical, biotechnology, and medical device companies in managing complex regulatory requirements and streamlining the drug development process. By combining deep functional expertise with digital transformation capabilities, Take Solutions facilitates data-driven decision-making and ensures compliance with global safety standards. Its portfolio encompasses strategic consulting and technology-enabled services designed to optimize clinical trial outcomes and accelerate time-to-market for new therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Outcome of Board Meeting | 2026-05-13 | English | |
| Please find enclosed herewith the Outcome of the Board Meeting held on Wednesday, May 13, 2026, inter alia approving change in name of the Company, alteration and adoption of Memorandum .... | 2026-05-13 | English | |
| Press Release | 2026-04-17 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-13 | English | |
| Press Release | 2026-04-06 | English | |
| Change in Auditors | 2026-03-26 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45564189 | Outcome of Board Meeting | 2026-05-13 | English | ||
| 45552703 | Please find enclosed herewith the Outcome of the Board Meeting held on Wednesday, May 13, 2026, inter alia approving change in name of the Company, alteration and adoption of Memorandum .... | 2026-05-13 | English | ||
| 42209881 | Press Release | 2026-04-17 | English | ||
| 42189767 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-13 | English | ||
| 42213664 | Press Release | 2026-04-06 | English | ||
| 42163155 | Change in Auditors | 2026-03-26 | English | ||
| 42163370 | Outcome of Board Meeting | 2026-03-26 | English | ||
| 42178686 | Resignation | 2026-03-25 | English | ||
| 42179973 | Trading Window | 2026-03-25 | English | ||
| 42190231 | Press Release | 2026-03-25 | English | ||
| 42170276 | General Updates | 2026-03-11 | English | ||
| 42187987 | Shareholders meeting | 2026-03-07 | English | ||
| 42188107 | Shareholders meeting | 2026-03-07 | English | ||
| 42193993 | Press Release | 2026-02-21 | English | ||
| 42175686 | Record Date | 2026-02-18 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Sharp Therapeutics Corp.
Preclinical drug discovery developing small molecule therap…
|
SHRX | CA | Professional, scientific and te… |
|
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
A contract research organization providing comprehensive dr…
|
2395 | JP | Professional, scientific and te… |
|
SHOUYAO HOLDINGS CO.,LTD
Develops small molecule drugs for oncology, metabolic, and …
|
688197 | CN | Professional, scientific and te… |
|
Silence Therapeutics plc
Clinical-stage biotech developing siRNA medicines to silenc…
|
SLN | GB | Professional, scientific and te… |
|
Silexion Therapeutics Corp
Clinical-stage biotech developing RNAi therapies for KRAS-d…
|
SLXN | KY | Professional, scientific and te… |
|
SillaJen, Inc.
Biotechnology company developing oncolytic viral therapies …
|
215600 | KR | Professional, scientific and te… |
|
Simris Group AB
Develops novel payloads for Antibody-Drug Conjugates from c…
|
SIMRIS | SE | Professional, scientific and te… |
|
Sino Biological Inc.
Provides biological reagents and CRO services for protein a…
|
301047 | CN | Professional, scientific and te… |
|
Sipai Health Technology Co., Ltd.
A medical technology company connecting healthcare stakehol…
|
314 | KY | Professional, scientific and te… |
|
Sirnaomics Ltd.
Clinical-stage RNA therapeutics company, first to achieve p…
|
2257 | KY | Professional, scientific and te… |
Take Solutions Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60381/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60381 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60381 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60381 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60381}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Take Solutions Ltd (id: 60381)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.